Esperion Therapeutics, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, Chairman
2022-06-01–present
J. Martin Carroll
Board Member
Esperion Therapeutics, Inc.
Chairman
Esperion Therapeutics, Inc.
Board Member
TherapeuticsMD, Inc. (TXMD)Equibles does not estimate personal net worth.
About J. Martin Carroll
J. Martin Carroll is recorded as Board Member at Esperion Therapeutics, Inc. since May 28, 2026, Chairman at Esperion Therapeutics, Inc. since June 1, 2022 and Board Member at TherapeuticsMD, Inc. (TXMD) since May 27, 2021. Esperion Therapeutics, Inc. reported in an 8-K filed June 1, 2026 that J. Martin Carroll was appointed Class I director, effective May 28, 2026. Esperion Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. TherapeuticsMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at TherapeuticsMD, Inc. includes Brian Bernick (CEO), Mark Glickman (CEO), Marlan D. Walker (CEO and General Counsel) and 7 others.
“to elect two Class I director nominees, J. Martin Carroll and Sheldon L. Koenig, to the Company's Board of Directors, each to hold office until the Company's 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified, subject to their earlier death, resignation or removal”
Affiliation history
-
Esperion Therapeutics, Inc.
Board Member
SEC 8-K
Current2026-05-28–present
-
Esperion Therapeutics, Inc.
Chairman
SEC 8-K
Current2022-06-01–present
-
Current
2021-05-27–present
-
Start not stated–2021-12-31
Company network
TherapeuticsMD, Inc.
Current role
TXMD
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2021-05-27–present
Leadership on record at TherapeuticsMD, Inc.
- Brian Bernick CEO
- Mark Glickman CEO
- Marlan D. Walker CEO, General Counsel
- Robert Finizio CEO, Board Member
- Tommy G. Thompson Chairman, Board Member
- Tommy Thompson Chairman
- James C. D'Arecca CFO
- Joseph Ziegler CFO
- Adam Miller CIO
- Cooper C. Collins Board Member